🏛️ Verified NIH Record • Updated 2026-08-25

Applying Neuromodulation to Boost the Efficacy of Motivational Interviewing (NCT07787572)

🟡 Not Yet Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: The Mind Research Network

🩺 Plain-English Summary (8th-Grade Level)

The goal of this clinical trial is to learn how adding brain stimulation to a brief counseling session affects adults with cannabis use disorder. The counseling session uses motivational interviewing, which helps people talk through their reasons for changing or not changing cannabis use. The brain stimulation is called transcranial alternating current stimulation (tACS). tACS uses electrodes on the scalp to give a very weak electrical current for a short time. The main questions it aims to answer are: * Does active tACS affect what participants say during the counseling session? * Does active tACS change brain activity after the session? * Is active tACS related to less cannabis use during the month after the session? Researchers will compare motivational interviewing with active tACS to motivational interviewing with placebo stimulation. Placebo stimulation uses the same setup but does not provide the active 30-minute stimulation. Participants will be assigned by chance to one of these groups, and neither participants nor the study staff member running the session will know which type of stimulation is used. Participants will complete questionnaires, breath and urine tests, a recorded counseling session during active or placebo stimulation, MEG and MRI brain scans, daily text-message check-ins about cannabis use, and follow-up questionnaires about one month later.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (3 items) and avoid the listed exclusions (13 items).

Location: The Mind Research Network — Albuquerque, New Mexico

Age range: 21 Years to 65 Years

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Usually NOT eligible if any of the following apply:

  • Exclusion Criteria:
  • currently engaged in treatment for any substance use disorder (SUD)
  • receiving treatment for any SUD within the prior 30 days
  • history of brain injury or major neurological diagnosis, vascular/neurodegenerative disorder, or complex primary headache disorder
  • evidence of current psychosis
  • past-year substance use disorder other than cannabis, alcohol, or nicotine
  • positive urine drug screen for any illicit drug other than cannabis
  • current or recent (past-month) medically significant withdrawal
  • MRI/tACS contraindications, including pregnancy
  • impaired hearing (psychotherapy using American Sign Language is not possible within the scope of this study)
  • insufficient corrected visual acuity to complete the assessment instruments
  • unable to read/speak English fluently

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

  • The Mind Research Network — Albuquerque, New Mexico

📞 Contact the Study Coordinator

Phone: (505) 226-2323

Email: enact@mrn.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Cannabis Use Disorder

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗